- This event has passed.
Venous Thrombosis Update – NYU Langone Medical Center
May 6, 2016 @ 7:00 AM - 4:30 PM$125
Venous Thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a national health crisis, occurring or reoccurring in an estimated 1 million patients annually. With the advent of new oral anticoagulants (NOACs) and innovative invasive techniques, the field of VTE diagnosis and treatment is ever-evolving. This one-day (8 hours) course is intended to provide attendees with robust and current insight into Venous Thromboembolic disease. Since VTE occurs throughout the population and often requires a multi-disciplinary treatment approach, we invite all specialties of providers as well as advanced Allied Health practitioners to attend this informative course. Topics will be varied and will include a VTE anatomical refresher, pathology of VTE, topics in both noninvasive and invasive treatment options, and issues for special populations including oncology and obstetric populations.
At the conclusion of this activity, participants should be able to:
- Articulate and follow the guidelines for management of DVT and PE. Participants shall develop treatment strategies that factor in new concepts concerning new pharmaceuticals and minimally invasive treatment
- Identify when to use the new anticoagulants and when not to treat; identify what surgical devices are now available as treatment options for submassive PE and when to use such surgical devices vs. when not to treat; and implement the updated guidelines for management of venous thromboembolism
- Identify the recent updates to current knowledge of managing DVT and PE
- Identify the different types of quality indicators (VCSS, Villalta Score, and Quality of Life score), where they are applicable, and how they are used in clinical practice to affect positive change in patient outcomes
- Identify patient safety and quality issues such as proper dosing of NOACs and the adverse effects of NOACs as well as when to intervene with surgery vs. medication.
Primary care physicians, vascular surgeons, orthopaedic surgeons, cardiologists, interventional radiologists, hematologists, nurses and nurse practitioners.